Literature DB >> 16807475

Chemotherapy advances in small cell lung cancer.

G Rosti1, O Carminati, M Monti, S Tamberi, M Marangolo.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16807475     DOI: 10.1093/annonc/mdj961

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Enhanced T-cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in mice.

Authors:  Erik E Johnson; Ilia N Buhtoiarov; Mark J Baldeshwiler; Mildred A R Felder; Nico Van Rooijen; Paul M Sondel; Alexander L Rakhmilevich
Journal:  J Immunother       Date:  2011-01       Impact factor: 4.456

2.  Extrapulmonary small cell carcinoma: involvement of the brain without evidence of extracranial malignancy by serial PET/CT scans.

Authors:  Christopher N Hueser; Nghi C Nguyen; Medhat Osman; Necat Havlioglu; Anjali J Patel
Journal:  World J Surg Oncol       Date:  2008-09-25       Impact factor: 2.754

3.  Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models.

Authors:  Kathleen R Whiteman; Holly A Johnson; Michele F Mayo; Charlene A Audette; Christina N Carrigan; Alyssa LaBelle; Lawrence Zukerberg; John M Lambert; Robert J Lutz
Journal:  MAbs       Date:  2014-01-08       Impact factor: 5.857

4.  Down-regulation of GRP78 is associated with the sensitivity of chemotherapy to VP-16 in small cell lung cancer NCI-H446 cells.

Authors:  Yingyan Wang; Wei Wang; Siyan Wang; Jiarui Wang; Shujuan Shao; Qi Wang
Journal:  BMC Cancer       Date:  2008-12-17       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.